Correlation Between Alvotech and Intellia Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alvotech and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alvotech and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alvotech and Intellia Therapeutics, you can compare the effects of market volatilities on Alvotech and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alvotech with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alvotech and Intellia Therapeutics.

Diversification Opportunities for Alvotech and Intellia Therapeutics

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Alvotech and Intellia is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Alvotech and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Alvotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alvotech are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Alvotech i.e., Alvotech and Intellia Therapeutics go up and down completely randomly.

Pair Corralation between Alvotech and Intellia Therapeutics

Given the investment horizon of 90 days Alvotech is expected to under-perform the Intellia Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Alvotech is 3.66 times less risky than Intellia Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Intellia Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  950.00  in Intellia Therapeutics on November 18, 2024 and sell it today you would earn a total of  120.00  from holding Intellia Therapeutics or generate 12.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Alvotech  vs.  Intellia Therapeutics

 Performance 
       Timeline  
Alvotech 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Alvotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Alvotech may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Intellia Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Intellia Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Alvotech and Intellia Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alvotech and Intellia Therapeutics

The main advantage of trading using opposite Alvotech and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alvotech position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.
The idea behind Alvotech and Intellia Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing